TrialThe New England journal of medicine2026
Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab.
Shaji Kumar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled itcites it
TrialThe New England journal of medicine2026
Shaji Kumar et al.PubMed ↗Publisher ↗
No numbers read from the abstract.